000 01853 a2200541 4500
005 20250516102124.0
264 0 _c20121126
008 201211s 0 0 eng d
022 _a1521-0103
024 7 _a10.1124/jpet.112.195925
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKita, Aya
245 0 0 _aSepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cOct 2012
300 _a178-83 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadministration & dosage
650 0 4 _aLymphoma, B-Cell
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aMice, SCID
650 0 4 _aNaphthoquinones
_xadministration & dosage
650 0 4 _aRadionuclide Imaging
650 0 4 _aRituximab
650 0 4 _aTreatment Outcome
650 0 4 _aXenograft Model Antitumor Assays
_xmethods
700 1 _aMitsuoka, Keisuke
700 1 _aKaneko, Naoki
700 1 _aNakata, Mari
700 1 _aYamanaka, Kentaro
700 1 _aJitsuoka, Makoto
700 1 _aMiyoshi, Sosuke
700 1 _aNoda, Akihiro
700 1 _aMori, Masamichi
700 1 _aNakahara, Takahito
700 1 _aSasamata, Masao
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 343
_gno. 1
_gp. 178-83
856 4 0 _uhttps://doi.org/10.1124/jpet.112.195925
_zAvailable from publisher's website
999 _c21937757
_d21937757